Adalyn Hetzel had just celebrated her second birthday in the spring of 2024 when doctors at Children’s Hospital of ...
Despite such guidelines, though, the investigators said there is a lack of evidence-based or widely accepted consensus on ...
Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...
The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...
New research from Dartmouth Health and Dartmouth Cancer Center reveals a glowing molecule designed to highlight soft-tissue sarcomas during surgery, paving the way for more precise tumor removal and ...
3don MSN
Small number of 'highly plastic' cancer cells drive disease progression and treatment resistance
A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...
A research-supported myofascial release system developed from Dr. Jacobs’ clinical practice and personal healing journey CLERMONT, FL, UNITED STATES, January 13, 2026 /EINPresswire.com/ — Dr. Joseph ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results